VYMBRU

Serial Number 98859237
730

Registration Progress

Application Filed
Nov 18, 2024
Under Examination
Jun 24, 2025
Approved for Publication
Apr 29, 2025
Published for Opposition
Apr 29, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Dec 24, 2025 49 days

Trademark Image

VYMBRU

Basic Information

Serial Number
98859237
Filing Date
November 18, 2024
Published for Opposition
April 29, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Oct 30, 2025
Application
Pending
Classes
005

Rights Holder

ONO PHARMACEUTICAL CO., LTD.

03
Address
1-5, Doshomachi 2-chome, Chuo-ku,
Osaka-shi, Osaka 541-8526
JP

Ownership History

ONO PHARMACEUTICAL CO., LTD.

Original Applicant
03
Osaka-shi, Osaka JP

ONO PHARMACEUTICAL CO., LTD.

Owner at Publication
03
Osaka-shi, Osaka JP

Legal Representation

Attorney
Perla M. Kuhn

USPTO Deadlines

Next Deadline
49 days remaining
NOA E-Mailed - SOU Required
Due Date
December 24, 2025
Extension Available
Until June 24, 2026

Application History

12 events
Date Code Type Description Documents
Oct 31, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 30, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 30, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 30, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 24, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 29, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 29, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 23, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 2, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 19, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 18, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 18, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis

Classification

International Classes
005